Home | My Profile | Contact Us
Research Trends Products  |   order gateway  |   author gateway  |   editor gateway  
Register | Forgot Password

Author Resources
 Author Gateway
 Article submission guidelines

Editor Resources
 Editor/Referee Gateway

 Regional Subscription Agents/Distributors
Current Topics in Pharmacology   Volumes    Volume 16 
Current status of recombinant antibodies in cancer therapy
Ron Wolchinsky, Yoram Reiter
Pages: 1 - 14
Number of pages: 14
Current Topics in Pharmacology
Volume 16 

Copyright © 2012 Research Trends. All rights reserved

Antibodies have come a long way from those first isolated by hybridoma over 30 years ago to modern engineered fragments, constructed by rational design. The use of antibodies in cancer therapy is increasing rapidly, with 11 antibodies approved over the past decade and more than 500 ongoing clinical trials involving monoclonal antibodies. The combination of the antibody`s inherent characteristics with the growing pool of tumour-specific antigens has generated a wide array of antibody-derived tools that are specifically designed to suppress and eliminate cancer cells. This review will examine some of the many novel antibodies and antibody-based approaches that are currently being developed for clinical application as the new generation of anti-cancer agent therapies.
View Full Article  


Buy this article
Buy this volume
Subscribe to this title
Shopping Cart

Quick Links
Search Products
Browse in Alphabetical Order : Journals
Browse by Subject Classification : Journals

Ordering Information Ordering Information
Downloadable forms Downloadable Forms